The International Community of Women Living with HIV Eastern Africa (ICWEA), in partnership with ICW_Kenya Chapter and DARE Organisation with support from AIDSFONDS, convened a webinar titled “Expanding HIV Prevention Options: Spotlight on the new HIV prevention technologies (DVR, LEN, CAB-LA).” The session will take place on Wednesday, August 13th 2025 at 3:00 PM EAT
This 90-minute dialogue aimed at examining the future of HIV prevention through a feminist and community-driven lens—focusing on the role of the Dapivirine Vaginal Ring (DVR) and other emerging tools in broadening choice and control (Lenacapavir-LEN, CAB-LA, & Oral PrEP), especially for women and adolescent girls. It followed the release of the UNAIDS Global AIDS Update 2025 and it came at a critical time when funding shifts, product rollouts, and advocacy efforts must align to ensure equity in access and agency.
The World Health Organization (WHO) released new recommending the use of injectable Lenacapavir (LEN) twice a year as an additional pre-exposure prophylaxis (PrEP) option for HIV prevention, in a landmark policy action that could help reshape the global HIV response. On the same note, The Global Fund announced it has signed an access agreement with Gilead Sciences to procure Lenacapavir, a long-acting injectable for HIV prevention, for low- and middle-income countries (LMICs). This marked the first time in history that an HIV prevention product will be introduced in LMICs at the same time as in high-income countries — a significant milestone for global health equity.
The webinar brought together invited speakers from WHO, UNAIDS, IPM, the Global Fund, UN Women and youth advocates. These key actors shared insights on guidance, policy, procurement, funding, advocacy, and youth engagement in sustaining momentum for DVR, LEN, CAB-LA, Injectable and Oral PrEP—emphasizing the need for community-centered, rights-based prevention programming.
It also explored how feminist movements, youth leadership, and intersectional approaches can strengthen demand creation, address stigma, and ensure that HIV prevention is inclusive, accessible, and accountable to those most affected. The conversation contributed to generating collective asks, shared strategies, and a joint communiqué to guide future advocacy and coordination.
Download the Transcript ICWEA HIV Prevention_Webinar Transcript
